DK0941066T3 - Kationisk lipid-nukleinsyre-komplekser - Google Patents

Kationisk lipid-nukleinsyre-komplekser

Info

Publication number
DK0941066T3
DK0941066T3 DK97934685T DK97934685T DK0941066T3 DK 0941066 T3 DK0941066 T3 DK 0941066T3 DK 97934685 T DK97934685 T DK 97934685T DK 97934685 T DK97934685 T DK 97934685T DK 0941066 T3 DK0941066 T3 DK 0941066T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
acid complexes
cationic lipid
lipid
suspension
Prior art date
Application number
DK97934685T
Other languages
Danish (da)
English (en)
Inventor
Rainer Bischoff
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK0941066T3 publication Critical patent/DK0941066T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK97934685T 1996-08-26 1997-08-25 Kationisk lipid-nukleinsyre-komplekser DK0941066T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96401819 1996-08-26
PCT/IB1997/001030 WO1998008489A1 (en) 1996-08-26 1997-08-25 Cationic lipid-nucleic acid complexes

Publications (1)

Publication Number Publication Date
DK0941066T3 true DK0941066T3 (da) 2004-02-23

Family

ID=8225285

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934685T DK0941066T3 (da) 1996-08-26 1997-08-25 Kationisk lipid-nukleinsyre-komplekser

Country Status (11)

Country Link
US (1) US6271208B1 (de)
EP (1) EP0941066B1 (de)
JP (1) JP2000516948A (de)
AT (1) ATE252891T1 (de)
AU (1) AU729077B2 (de)
CA (1) CA2264140A1 (de)
DE (1) DE69725877T2 (de)
DK (1) DK0941066T3 (de)
ES (1) ES2208936T3 (de)
PT (1) PT941066E (de)
WO (1) WO1998008489A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509032B1 (en) 1991-08-28 2003-01-21 Mcmaster University Cationic amphiphiles
US6008202A (en) 1995-01-23 1999-12-28 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5981501A (en) * 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
EP0904282B1 (de) * 1996-04-12 2001-12-05 University Of Pittsburgh Neue kationische cholesterin derivate mit zyklischen polaren gruppen
US6093816A (en) * 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6410328B1 (en) * 1998-02-03 2002-06-25 Protiva Biotherapeutics Inc. Sensitizing cells to compounds using lipid-mediated gene and compound delivery
EP1013772A1 (de) * 1998-12-21 2000-06-28 Transgene S.A. Verfahren zur Herstellung einer stabilen Posiplexe-Suspension
DE19944262A1 (de) * 1999-09-15 2001-03-29 Cardiogene Gentherapeutische S Pharmazeutische Zusammensetzung in Form eines Nukleinsäure-Lipid-Komplexes, ihre Herstellung und Verwendung in der Gentherapie
US7189705B2 (en) * 2000-04-20 2007-03-13 The University Of British Columbia Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
AU2073002A (en) * 2000-11-29 2002-06-11 Aventis Pharm Prod Inc Neutral and anionic colloidal particles for gene delivery
CA2445947A1 (en) * 2001-04-30 2002-11-07 Targeted Genetics Corporation Lipid-comprising drug delivery complexes and methods for their production
EP1359228B1 (de) * 2002-04-23 2013-11-27 Accenture Global Services Limited Nukleinsäure authentifikation mittels detektion des streulichtes
US20040180438A1 (en) * 2002-04-26 2004-09-16 Pachuk Catherine J. Methods and compositions for silencing genes without inducing toxicity
AU2003266014B2 (en) * 2002-05-06 2009-05-14 Alnylam Pharmaceuticals, Inc. Methods for delivery of nucleic acids
AU2003274906A1 (en) * 2002-07-31 2004-02-16 Nucleonics, Inc. Double stranded rna structures and constructs, and methods for generating and using the same
US20040187445A1 (en) * 2003-03-28 2004-09-30 Hildebrand John Joseph Gripping arm assembly for loading a filled inner container into an outer container
ES2315721T5 (es) 2003-10-23 2012-08-24 Otsuka Pharmaceutical Co., Ltd. Formulación de aripiprazol inyectable estéril de liberación controlada y procedimiento
EP1792927B1 (de) 2004-09-22 2013-03-06 Nippon Kayaku Kabushiki Kaisha Neues blockcopolymer, micellenzubereitung und antikrebsmittel, das diese als wirkbestandteil enthält
WO2007111211A1 (ja) 2006-03-28 2007-10-04 Nippon Kayaku Kabushiki Kaisha タキサン類の高分子結合体
JP5181347B2 (ja) 2006-05-18 2013-04-10 日本化薬株式会社 ポドフィロトキシン類の高分子結合体
US8334364B2 (en) 2006-11-06 2012-12-18 Nipon Kayaku Kabushiki Kaisha High-molecular weight derivative of nucleic acid antimetabolite
WO2008056654A1 (en) 2006-11-08 2008-05-15 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
UA97286C2 (ru) 2007-07-31 2012-01-25 Оцука Фармасьютикал Ко., Лтд. Способ изготовления суспензии арипипразола и лиофилизированного состава
USRE46190E1 (en) 2007-09-28 2016-11-01 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of steroids
KR101589582B1 (ko) * 2008-03-18 2016-01-28 니폰 가야꾸 가부시끼가이샤 생리활성물질의 고분자량 결합체
US9149540B2 (en) 2008-05-08 2015-10-06 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of folic acid or folic acid derivative
JP5299424B2 (ja) * 2008-06-19 2013-09-25 日本新薬株式会社 薬物担体
JP5544357B2 (ja) 2009-05-15 2014-07-09 日本化薬株式会社 水酸基を有する生理活性物質の高分子結合体
NZ600616A (en) 2009-12-01 2014-11-28 Shire Human Genetic Therapies Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
WO2012067138A1 (ja) 2010-11-17 2012-05-24 日本化薬株式会社 新規なシチジン系代謝拮抗剤の高分子誘導体
WO2012075040A2 (en) 2010-11-30 2012-06-07 Shire Human Genetic Therapies, Inc. mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
KR102128248B1 (ko) 2011-06-08 2020-07-01 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
US9346923B2 (en) 2011-09-11 2016-05-24 Nippon Kayaku Kabushiki Kaisha Method for manufacturing block copolymer
US20150267192A1 (en) 2012-06-08 2015-09-24 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
AU2014236396A1 (en) 2013-03-14 2015-08-13 Shire Human Genetic Therapies, Inc. Methods for purification of messenger RNA
DK2968586T3 (en) 2013-03-14 2018-10-08 Translate Bio Inc CFTR MRNA COMPOSITIONS AND RELATED PROCEDURES AND APPLICATIONS
CN110974981A (zh) * 2013-07-23 2020-04-10 野草莓树生物制药公司 用于递送信使rna的组合物和方法
MX2016005239A (es) 2013-10-22 2016-08-12 Shire Human Genetic Therapies Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
WO2015061500A1 (en) 2013-10-22 2015-04-30 Shire Human Genetic Therapies, Inc. Mrna therapy for argininosuccinate synthetase deficiency
JP6571679B2 (ja) 2014-04-25 2019-09-04 トランスレイト バイオ， インコーポレイテッド メッセンジャーｒｎａの精製方法
AU2018224326B2 (en) 2017-02-27 2024-01-04 Translate Bio, Inc. Novel codon-optimized CFTR mRNA
MA49138A (fr) 2017-05-16 2020-03-25 Translate Bio Inc Traitement de la fibrose kystique par administration d'arnm à codons optimisés codant pour la cftr
KR102056144B1 (ko) 2018-03-08 2019-12-16 주식회사 파마리서치프로덕트 Dna 단편 혼합물이 고농도로 함유된 유동성을 갖는 액제 조성물 및 이의 제조방법
AU2019325702A1 (en) 2018-08-24 2021-02-25 Translate Bio, Inc. Methods for purification of messenger RNA

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5225212A (en) * 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5527528A (en) 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
EP0826063A1 (de) * 1995-04-25 1998-03-04 Vical Incorporated Einzelfläschehene formulierungen von dna (lipid-komplexen)
JPH11508231A (ja) * 1995-05-26 1999-07-21 ソマティックス セラピー コーポレイション 安定な脂質／核酸複合体を含む送達ビヒクル
ATE285477T1 (de) * 1995-06-07 2005-01-15 Inex Pharmaceutical Corp Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer
US5830878A (en) * 1995-06-07 1998-11-03 Megabios Corporation Cationic lipid: DNA complexes for gene targeting
US5705385A (en) * 1995-06-07 1998-01-06 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5932241A (en) * 1995-06-07 1999-08-03 Valentis, Incorporated Cationic lipid DNA complexes for gene targeting

Also Published As

Publication number Publication date
CA2264140A1 (en) 1998-03-05
ATE252891T1 (de) 2003-11-15
DE69725877D1 (de) 2003-12-04
US6271208B1 (en) 2001-08-07
EP0941066A1 (de) 1999-09-15
ES2208936T3 (es) 2004-06-16
AU729077B2 (en) 2001-01-25
JP2000516948A (ja) 2000-12-19
WO1998008489A1 (en) 1998-03-05
EP0941066B1 (de) 2003-10-29
PT941066E (pt) 2004-03-31
AU3781597A (en) 1998-03-19
DE69725877T2 (de) 2004-07-22

Similar Documents

Publication Publication Date Title
DE69725877D1 (de) Kationische lipid-nukleinsäure komplexe
DE69324367T2 (de) Kationische lipide
EA200000765A1 (ru) Получение липидной смеси и фосфолипидная суспензия, содержащая липидную смесь
BG102758A (en) Method for improving of contrast means
MX9701397A (es) Emulsiones topicas de ketoconazol.
FR2415099A1 (fr) Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
BG92804A (bg) 4-бензоилизоксазолови производни
EA200000239A1 (ru) Стимуляторы секреции гормона роста
PT76312B (en) Process for preparing 1,2,4-triazine and pyrazine derivatives
MX9603465A (es) N-pirazolilanilinas y n-pirazolilaminopiridinas como agentes pesticidas.
DE60027765D1 (de) Verfahren zur herstellung von mechanischer pulpe
DE3681133D1 (de) Verfahren zur herstellung einer polysaccharid-in-oel-dispersion und so hergestellte dispersion.
FR2372817A1 (fr) Derives d'acides thiazolidinecarboxyliques et d'acides apparentes, utiles comme agents anti-hypertension
ES446173A1 (es) Procedimiento con su dispositivo de realizacion para la so- lubilizacion de una suspension de cascina en polvo en medio acuoso.
ATE305771T1 (de) Verfahren zur herstellung von vitaminpulvern
ATE207892T1 (de) Verfahren zur herstellung von dithiobis- alkanesulfonaten und phosphonaten
EP0642507A4 (en) Catalytic antibodies against cocaine and methods of using and producing same.
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
TR199802019T2 (xx) Terap�tik amidleri stereoselektif olarak haz�rlamak i�in enzimatik y�ntem.
EP1001963A4 (de) Nukleinsäureleitern
ES549485A0 (es) Procedimiento para preparar acidos 2-carbomoilnicotinicos y 3-quinolincarboxilicos.
RU94040182A (ru) Эмульсионное взрывчатое вещество
AU1913995A (en) Paper opacifier
ATE30014T1 (de) Derivate der 2,2-diaethoxypropionsaeure.
SE8400118D0 (sv) Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation